Nav: Home

The path of breast-to-brain cancer metastasis

September 18, 2019

In 2018, breast cancer was the most common cancer in women worldwide, accounting for about a quarter of all reported cancers. One of the biggest problems with any type of cancer is metastasis; and when breast cancer metastasizes, the brain is a common destination.

The prevalence of breast-to-brain metastases has led scientists to suspect that there is an underlying rationale for why breast cancer cells seek out and seed tumor growths in the brain. Elucidating the rationale might give us the means to minimize breast-to-brain metastases or even prevent them altogether.

Publishing in Nature, scientists at EPFL's Swiss Institute for Experimental Cancer Research (ISREC) have discovered that this process involves the "N-methyl-D-aspartate receptor" (NMDAR), which is found on the cell membranes of neurons and is involved in the transmission of nerve impulses. The NMDAR is activated by the amino acid glutamate, released from pre-synaptic neurons during synaptic transmission of such impulses.

The ISREC group has shown in the past that glutamate-stimulated NMDAR signaling helps both neuroendocrine and ductal pancreatic tumors grow invasively, and that this co-opted neuronal signaling circuit is generally associated with a poor treatment prognosis in a variety of cancer types. So when the researchers began looking for suspects in breast-to-brain metastases, the NMDAR was at the top of the list.

The investigation paid off: The researchers grew breast-to-brain metastasis cells in the lab to study their relationship to the NMDAR. And, sure enough, the cells were found to co-opt the entire system by which the NMDAR relays its effects to neurons - what biologists refer to as a "signaling pathway".

It seems then that a key to metastasizing to the brain involves turning on the NMDAR. Although some cancer cells secrete sufficient glutamate to auto-activate NMDAR, the current study found that it's not sufficient in breast cancer cells. So, how might they activate the NMDAR receptor?

In a breakthrough discovery, the researchers found that the breast cancer cells form "fake" synapses with the neurons that normally secrete glutamate as a neurotransmitter. The synapse is "pseudo-tripartite" because it resembles the tripartite synapse between two neurons and the surrounding non-neuronal, supporting cells (e.g. astrocytes).

Once the synapses are formed, the neurons supply the breast-cancer cells with ample glutamate, and the NMDAR receptor turns on, providing what the authors call "an insidious rationale for brain metastasis".

"This remarkable mechanism for fueling the growth of metastatic tumors in the brain adds to an expanding knowledge base about the parameters of metastasis that we hope will be applicable to prevention and therapy," says Douglas Hanahan. "The challenge is the insidious proximity of the cancer cells to normal neuronal synapses, for which NMDAR signaling is crucial. Thus, in future research, we and others will need to search for specific vulnerabilities in glutamate-fueled metastatic breast cancer cells that can be targeted therapeutically to block brain metastasis, while sparing the adjacent normal neurons."
-end-
Professor Hanahan's lab is part of the Swiss Institute for Experimental Cancer Research (ISREC) within the School of Life Sciences at EPFL. ISREC@EPFL is part of the Swiss Cancer Center Léman (SCCL), a multidisciplinary alliance pursuing fundamental, translational, and clinical cancer research. The SCCL founding members are the Lausanne University Hospital (CHUV), the Geneva University Hospitals (HUG), the universities of Lausanne (UNIL) and Geneva (UNIGE), and EPFL.

Other contributors

Children's National Medical Center, Washington DC

EPFL BioEM Facility

EPFL Brain Mind Institute

University of Bern

University of Cambridge

University of Lausanne (UNIL)

Swiss Institute of Bioinformatics

Reference

Qiqun Zeng, Iacovos P. Michael, Peng Zhang, Sadegh Saghafinia, Graham Knott, Wei Jiao, Brian D. McCabe, José A. Galván, Hugh P. C. Robinson, Inti Zlobec, Giovanni Ciriello, Douglas Hanahan. Synaptic proximity enables NMDAR signaling to promote brain metastasis. Nature 18 September 2019. DOI: 10.1038/s41586-019-1576-6

Ecole Polytechnique Fédérale de Lausanne

Related Breast Cancer Articles:

Partial breast irradiation effective treatment option for low-risk breast cancer
Partial breast irradiation produces similar long-term survival rates and risk for recurrence compared with whole breast irradiation for many women with low-risk, early stage breast cancer, according to new clinical data from a national clinical trial involving researchers from The Ohio State University Comprehensive Cancer Center - Arthur G.
Breast screening linked to 60 per cent lower risk of breast cancer death in first 10 years
Women who take part in breast screening have a significantly greater benefit from treatments than those who are not screened, according to a study of more than 50,000 women.
More clues revealed in link between normal breast changes and invasive breast cancer
A research team, led by investigators from Georgetown Lombardi Comprehensive Cancer Center, details how a natural and dramatic process -- changes in mammary glands to accommodate breastfeeding -- uses a molecular process believed to contribute to survival of pre-malignant breast cells.
Breast tissue tumor suppressor PTEN: A potential Achilles heel for breast cancer cells
A highly collaborative team of researchers at the Medical University of South Carolina and Ohio State University report in Nature Communications that they have identified a novel pathway for connective tissue PTEN in breast cancer cell response to radiotherapy.
Computers equal radiologists in assessing breast density and associated breast cancer risk
Automated breast-density evaluation was just as accurate in predicting women's risk of breast cancer, found and not found by mammography, as subjective evaluation done by radiologists, in a study led by researchers at UC San Francisco and Mayo Clinic.
More Breast Cancer News and Breast Cancer Current Events

Best Science Podcasts 2019

We have hand picked the best science podcasts for 2019. Sit back and enjoy new science podcasts updated daily from your favorite science news services and scientists.
Now Playing: TED Radio Hour

Rethinking Anger
Anger is universal and complex: it can be quiet, festering, justified, vengeful, and destructive. This hour, TED speakers explore the many sides of anger, why we need it, and who's allowed to feel it. Guests include psychologists Ryan Martin and Russell Kolts, writer Soraya Chemaly, former talk radio host Lisa Fritsch, and business professor Dan Moshavi.
Now Playing: Science for the People

#537 Science Journalism, Hold the Hype
Everyone's seen a piece of science getting over-exaggerated in the media. Most people would be quick to blame journalists and big media for getting in wrong. In many cases, you'd be right. But there's other sources of hype in science journalism. and one of them can be found in the humble, and little-known press release. We're talking with Chris Chambers about doing science about science journalism, and where the hype creeps in. Related links: The association between exaggeration in health related science news and academic press releases: retrospective observational study Claims of causality in health news: a randomised trial This...